-
Something wrong with this record ?
Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics
P. Dundr, N. Singh, B. Nožičková, K. Němejcová, M. Bártů, I. Stružinská
Language English Country Great Britain
Document type Journal Article, Review
Grant support
AZV NV19-03-00007
Ministerstvo Zdravotnictví Ceské Republiky
Conceptual development of research organization 64165, General University Hospital in Prague
Ministerstvo Zdravotnictví Ceské Republiky
Progress Q28/LF1
Univerzita Karlova v Praze
UNCE204065
Univerzita Karlova v Praze
SVV260367
Univerzita Karlova v Praze
CZ.02.1.01/0.0/0.0/18_046/0015959
European Regional Development Fund
BBMRI_CZ LM2018125
European Regional Development Fund
NLK
BioMedCentral
from 2006-12-01
BioMedCentral Open Access
from 2006
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2006-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
Springer Nature OA/Free Journals
from 2006-12-01
- MeSH
- Gastrointestinal Tract pathology MeSH
- Humans MeSH
- Adenocarcinoma, Mucinous pathology MeSH
- Ovarian Neoplasms pathology MeSH
- Pancreas pathology MeSH
- Peritoneal Neoplasms pathology MeSH
- Pseudomyxoma Peritonei diagnosis pathology MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
BACKGROUND: Making the distinction between primary mucinous and metastatic ovarian tumors is often difficult, especially in tumors with a primary source from the gastrointestinal tract, pancreas and biliary tree. The aim of the following paper is to provide an overview of the problematics, with a focus on the possibilities of the differential diagnosis at the macroscopic, microscopic and immunohistochemical level. MAIN BODY: The three main aspects of mucinous ovarian tumors are described in detail, including the comparison of the available diagnostic algorithms based on the evaluation of mostly macroscopic features, characterization of the spectrum of microscopic features, and a detailed analysis of the immunophenotype comparing 20 antibodies with the assessment of their statistical significance for differential diagnosis purposes. Specific features, including Krukenberg tumor and pseudomyxoma peritonei, are also discussed. CONCLUSION: Despite the growing knowledge of the macroscopic and microscopic features of ovarian mucinous tumors and the availability of a wide range of immunohistochemical antibodies useful in this setting, there still remains a group of tumors which cannot be precisely classified without close clinical-pathological cooperation.
Blizard Institute of Core Pathology Queen Mary University of London London UK
Department of Cellular Pathology Barts Health NHS Trust Queen Mary University of London London UK
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004540
- 003
- CZ-PrNML
- 005
- 20220127145152.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13000-021-01079-2 $2 doi
- 035 __
- $a (PubMed)33706757
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Dundr, Pavel $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic. pavel.dundr@vfn.cz
- 245 10
- $a Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics / $c P. Dundr, N. Singh, B. Nožičková, K. Němejcová, M. Bártů, I. Stružinská
- 520 9_
- $a BACKGROUND: Making the distinction between primary mucinous and metastatic ovarian tumors is often difficult, especially in tumors with a primary source from the gastrointestinal tract, pancreas and biliary tree. The aim of the following paper is to provide an overview of the problematics, with a focus on the possibilities of the differential diagnosis at the macroscopic, microscopic and immunohistochemical level. MAIN BODY: The three main aspects of mucinous ovarian tumors are described in detail, including the comparison of the available diagnostic algorithms based on the evaluation of mostly macroscopic features, characterization of the spectrum of microscopic features, and a detailed analysis of the immunophenotype comparing 20 antibodies with the assessment of their statistical significance for differential diagnosis purposes. Specific features, including Krukenberg tumor and pseudomyxoma peritonei, are also discussed. CONCLUSION: Despite the growing knowledge of the macroscopic and microscopic features of ovarian mucinous tumors and the availability of a wide range of immunohistochemical antibodies useful in this setting, there still remains a group of tumors which cannot be precisely classified without close clinical-pathological cooperation.
- 650 _2
- $a mucinózní adenokarcinom $x patologie $7 D002288
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a gastrointestinální trakt $x patologie $7 D041981
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory vaječníků $x patologie $7 D010051
- 650 _2
- $a pankreas $x patologie $7 D010179
- 650 _2
- $a peritoneální nádory $x patologie $7 D010534
- 650 _2
- $a pseudomyxom peritonea $x diagnóza $x patologie $7 D011553
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Singh, Naveena $u Department of Cellular Pathology, Barts Health NHS Trust, Queen Mary University of London, London, UK $u Blizard Institute of Core Pathology, Queen Mary University of London, London, UK
- 700 1_
- $a Nožičková, Barbora $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic
- 700 1_
- $a Němejcová, Kristýna $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic
- 700 1_
- $a Bártů, Michaela $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic
- 700 1_
- $a Stružinská, Ivana $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, 128 00, Prague 2, Czech Republic
- 773 0_
- $w MED00165474 $t Diagnostic pathology $x 1746-1596 $g Roč. 16, č. 1 (2021), s. 20
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33706757 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145148 $b ABA008
- 999 __
- $a ok $b bmc $g 1751865 $s 1155689
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 16 $c 1 $d 20 $e 20210311 $i 1746-1596 $m Diagnostic pathology $n Diagn Pathol $x MED00165474
- GRA __
- $a AZV NV19-03-00007 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a Conceptual development of research organization 64165, General University Hospital in Prague $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a Progress Q28/LF1 $p Univerzita Karlova v Praze
- GRA __
- $a UNCE204065 $p Univerzita Karlova v Praze
- GRA __
- $a SVV260367 $p Univerzita Karlova v Praze
- GRA __
- $a CZ.02.1.01/0.0/0.0/18_046/0015959 $p European Regional Development Fund
- GRA __
- $a BBMRI_CZ LM2018125 $p European Regional Development Fund
- LZP __
- $a Pubmed-20220113